OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
Joseph G.W. McCarter, David Nemirovsky, Christopher Famulare, et al.
Blood Advances (2023) Vol. 7, Iss. 17, pp. 5000-5013
Open Access | Times Cited: 13
Joseph G.W. McCarter, David Nemirovsky, Christopher Famulare, et al.
Blood Advances (2023) Vol. 7, Iss. 17, pp. 5000-5013
Open Access | Times Cited: 13
Showing 13 citing articles:
Pathophysiology of Acute Myeloid Leukemia
Franziska Wachter, Yana Pikman
Acta Haematologica (2024) Vol. 147, Iss. 2, pp. 229-246
Closed Access | Times Cited: 10
Franziska Wachter, Yana Pikman
Acta Haematologica (2024) Vol. 147, Iss. 2, pp. 229-246
Closed Access | Times Cited: 10
Venetoclax Resistance in Acute Myeloid Leukemia
Sylvain Garciaz, Marie‐Anne Hospital, Yves Collette, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 8
Sylvain Garciaz, Marie‐Anne Hospital, Yves Collette, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 8
Large-scale screens identify a 19-Gene MitoScore for improved risk assessment in acute myeloid leukemia
Liting Niu, Hanfei Guo, Yijing Zhao
Mitochondrion (2025) Vol. 82, pp. 102011-102011
Closed Access
Liting Niu, Hanfei Guo, Yijing Zhao
Mitochondrion (2025) Vol. 82, pp. 102011-102011
Closed Access
Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt‐related transcription factor 1 mutation: A single‐center retrospective analysis
Lin‐Ya Wang, Yao Li, Qian Jiang, et al.
Hematological Oncology (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 2
Lin‐Ya Wang, Yao Li, Qian Jiang, et al.
Hematological Oncology (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 2
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification
Michael J. Hochman, Megan Othus, Robert P. Hasserjian, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1915-1918
Open Access | Times Cited: 6
Michael J. Hochman, Megan Othus, Robert P. Hasserjian, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1915-1918
Open Access | Times Cited: 6
Hematopoietic Stem Cell: Regulation and Nutritional Intervention
Siyuan Sun, Yingxue Han, Yumei Lei, et al.
Nutrients (2023) Vol. 15, Iss. 11, pp. 2605-2605
Open Access | Times Cited: 5
Siyuan Sun, Yingxue Han, Yumei Lei, et al.
Nutrients (2023) Vol. 15, Iss. 11, pp. 2605-2605
Open Access | Times Cited: 5
Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype
Ruifang Zheng, Franklin Fuda, Jeffrey Gagan, et al.
Leukemia Research Reports (2023) Vol. 21, pp. 100410-100410
Open Access | Times Cited: 5
Ruifang Zheng, Franklin Fuda, Jeffrey Gagan, et al.
Leukemia Research Reports (2023) Vol. 21, pp. 100410-100410
Open Access | Times Cited: 5
Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications
Francesca Guijarro, Sandra Castaño‐Díez, Carlos Jiménez‐Vicente, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8669-8669
Open Access | Times Cited: 1
Francesca Guijarro, Sandra Castaño‐Díez, Carlos Jiménez‐Vicente, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8669-8669
Open Access | Times Cited: 1
Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia‐related mutations in first remission
Ling Jiang, Jiaying Cheng, Junya Sun, et al.
British Journal of Haematology (2024)
Open Access | Times Cited: 1
Ling Jiang, Jiaying Cheng, Junya Sun, et al.
British Journal of Haematology (2024)
Open Access | Times Cited: 1
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine
Amanda Winters, Mohd Minhajuddin, Brett M. Stevens, et al.
Haematologica (2023)
Open Access | Times Cited: 4
Amanda Winters, Mohd Minhajuddin, Brett M. Stevens, et al.
Haematologica (2023)
Open Access | Times Cited: 4
Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity
Pallavi Galera, Deepika Dilip, Andriy Derkach, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Pallavi Galera, Deepika Dilip, Andriy Derkach, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patient
Michael Heuser, Rabia Shahswar
Hematology (2024) Vol. 2024, Iss. 1, pp. 158-167
Closed Access
Michael Heuser, Rabia Shahswar
Hematology (2024) Vol. 2024, Iss. 1, pp. 158-167
Closed Access
Association of genetic predisposition studies in CYP1A1 polymorphism studies in acute myeloid leukemia
Abdullah Farasani
Saudi Journal of Biological Sciences (2023) Vol. 31, Iss. 3, pp. 103917-103917
Open Access | Times Cited: 1
Abdullah Farasani
Saudi Journal of Biological Sciences (2023) Vol. 31, Iss. 3, pp. 103917-103917
Open Access | Times Cited: 1
